Hidradenitis Suppurativa
Conditions
Brief summary
Hidradenitis suppurativa (HS) is a common and debilitating skin disease that is poorly understood and understudied. As a result, little is known about disease prognosis and few effective treatments exist for this condition. This prospective observational cohort study aims to comprehensively characterize the clinical and biological features of HS. The results of this research will provide a basis for the development of an HS clinical classification system and identification of potential treatments for HS.
Interventions
None listed
Sponsors
University of California, San Francisco
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
13 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
Hidradenitis Suppurativa Patients Inclusion Criteria: 1. Age 13 years or older 2. Diagnosis of HS clinically-confirmed by a physician
Exclusion criteria
1\. Inability to give informed consent or have a parent/guardian who is able and willing to give informed consent. Healthy Volunteer Inclusion Criteria: 1. No history of chronic skin conditions 2. No recent history of antibiotic use
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary aim of this study is to identify clinical and biologic characteristics of hidradenitis suppurativa. | 2016-2026 |
Secondary
| Measure | Time frame |
|---|---|
| Secondary aims include correlating alterations in clinical and biological characteristics with disease status, and identifying genetic variants that predict disease progression or response to therapy. | 2016-2026 |
Countries
United States
Contacts
CONTACTKaelin Chatterley
PRINCIPAL_INVESTIGATORHaley B Naik, MD, MHSc, FAAD
University of California, San Francisco
Outcome results
None listed